Page 2 - Supernus Pharmaceuticals News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Supernus pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Supernus Pharmaceuticals Today - Breaking & Trending Today

Congress Wealth Management LLC DE Cuts Stock Holdings in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN)

Congress Wealth Management LLC DE trimmed its holdings in shares of Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN – Free Report) by 18.9% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 129,051 shares of the specialty pharmaceutical company’s stock after selling 30,095 shares during the quarter. Congress […] ....

United States , Padmanabhp Bhatt , Piper Sandler , Dimensional Fund Advisors , Securities Exchange Commission , Supernus Pharmaceuticals Company Profile , Quarter For Supernus Pharmaceuticals , Loomis Sayles Co , Armistice Capital , Exchange Commission , Norges Bank , News Ratings For Supernus Pharmaceuticals Daily , Polar Capital Holdings Plc , Supernus Pharmaceuticals Inc , Supernus Pharmaceuticals , Supernus Pharmaceuticals Price Performance , Congress Wealth Management , Free Report , Wealth Management , Capital Holdings Plc , Fund Advisors , Get Free Report , Supernus Pharmaceuticals Daily ,

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc.

/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. ("Supernus" or the "Company") (NASDAQ: SUPN).. ....

New York , United States , Tel Aviv , France General , City Of , United Kingdom , Los Angeles , Abrahaml Pomerantz , Danielle Peyton , Prnewswire Pomerantz , Supernus Pharmaceuticals Inc , Company New Drug Application , Supernus Pharmaceuticals , Complete Response Letter , New Drug Application ,

Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy

Supernus Announces Promising Interim Data from Ongoing Open-Label Phase 2a Study of SPN-817 in Epilepsy
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Timothyc Dec , Peter Vozzo , Jack Khattar , Jacka Khattar , Drug Administration , Supernus Pharmaceuticals Inc , Supernus Pharmaceuticals , Exchange Commission , Company Investor Relations , Securities Exchange , Announces Promising Interim Data , Ongoing Open Label Phase , Investor Relations , Orphan Drug , Dravet Syndrome , Lennox Gastaut Syndrome , Percent Change , Clinical Global Impression Severity , Private Securities Litigation Reform Act , Securities Exchange Act , Senior Vice President ,

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN

Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc. - SUPN
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Tel Aviv , France General , United States , City Of , United Kingdom , New York , Abrahaml Pomerantz , Los Angeles , Danielle Peyton , Supernus Pharmaceuticals Inc , Company New Drug Application , Prnewswire Pomerantz , Supernus Pharmaceuticals , Complete Response Letter , New Drug Application ,

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Supernus Pharmaceuticals, Inc.

/PRNewswire/ Pomerantz LLP is investigating claims on behalf of investors of Supernus Pharmaceuticals, Inc. ("Supernus" or the "Company") (NASDAQ: SUPN).. ....

City Of , United Kingdom , New York , United States , Tel Aviv , France General , Abrahaml Pomerantz , Los Angeles , Danielle Peyton , Company New Drug Application , Prnewswire Pomerantz , Supernus Pharmaceuticals Inc , Supernus Pharmaceuticals , Complete Response Letter , New Drug Application ,